Lillian Siu: Submit an abstract by 11:59 PM ET April 9 for ASCOBT24

Lillian Siu shared on X/Twitter:

”ASCOBT24, ASCO Aug 8-10, 2024 in Yokohama, Japan. Chaired by the dynamic Melvin LK Chua. Exciting agenda with relevant topics across disciplines. Submit abstract by 11:59 PM ET April 9. Learn more.”

Source: Lillian Siu/X

Lillian Siu is the President-Elect of the American Association for Cancer Research (AACR) and 2024 Recipient of American Society of Clinical Oncology (ASCO) Karnofsky Award (the Nobel Prize of oncology world)! Lillian Siu is a Professor of Medicine at the University of Toronto (Canada), senior medical oncologist, Director of the Phase I Program, Co-Director of the Bras and Family Drug Development Program and the Clinical Lead for the Tumor Immunotherapy Program at the Princess Margaret Cancer Centre. She holds the BMO Chair in Precision Genomics (2016-2026).  Dr. Siu served on the Board of Directors for the American Society of Clinical Oncology (ASCO), was a member of the Nomination Committee for the American Association for Cancer Research (AACR) (2014-2016), and currently serves on the AACR Board of Directors. She is a scientific editor for Cancer Discovery and is on the editorial board for JAMA Oncology.